| |
EQ-5D-3L at 6 months (mean)
|
EQ-5D-3L at 12 months (mean)
|
Difference between 12 and 6 months EQ-5D-3L (95% CI)
|
Effect size (Cohen’s D)a
|
n
|
% reporting 3L score increase
|
|---|
|
Barthel Index
|
|
Improved
|
0.79
|
0.88
|
0.09 (0.00 to 0.18)
|
0.58
|
11
|
55
|
|
No change
|
0.87
|
0.90
|
0.02 (− 0.01 to 0.07)
|
0.22
|
37
|
41
|
|
Worsened
|
0.69
|
0.63
|
− 0.03 (− 0.13 to 0.07)
|
− 0.10
|
15
|
40
|
| |
EQ-5D-5L at 6 months (mean)
|
EQ-5D-5L at 12 months (mean)
|
Difference between 12 and 6 months EQ-5D-5L (95% CI)
|
Effect size (Cohen’s D)
|
n
|
% reporting 5L score increase
|
|---|
|
Barthel Index
|
|
Improved
|
0.73
|
0.85
|
0.12 (0.02 to 0.22)
|
0.78
|
11
|
64
|
|
No change
|
0.84
|
0.87
|
0.03 (− 0.01 to 0.08)
|
0.21
|
37
|
43
|
|
Worsened
|
0.68
|
0.62
|
− 0.06 (− 0.15 to 0.03)
|
− 0.21
|
15
|
27
|
- aCohen’s D effect sizes of between 0.2 and 0.5 are considered small, 0.5 and 0.8 moderate and > 0.8 large
